Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD137 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global CD137 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Flow Cytometry
1.3.3 ELISA
1.3.4 Immunoprecipitation
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CD137 Antibody Market Perspective (2018-2029)
2.2 Global CD137 Antibody Growth Trends by Region
2.2.1 CD137 Antibody Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 CD137 Antibody Historic Market Size by Region (2018-2024)
2.2.3 CD137 Antibody Forecasted Market Size by Region (2024-2029)
2.3 CD137 Antibody Market Dynamics
2.3.1 CD137 Antibody Industry Trends
2.3.2 CD137 Antibody Market Drivers
2.3.3 CD137 Antibody Market Challenges
2.3.4 CD137 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue CD137 Antibody by Players
3.1.1 Global CD137 Antibody Revenue by Players (2018-2024)
3.1.2 Global CD137 Antibody Revenue Market Share by Players (2018-2024)
3.2 Global CD137 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of CD137 Antibody, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global CD137 Antibody Market Concentration Ratio
3.4.1 Global CD137 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD137 Antibody Revenue in 2022
3.5 Global Key Players of CD137 Antibody Head office and Area Served
3.6 Global Key Players of CD137 Antibody, Product and Application
3.7 Global Key Players of CD137 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CD137 Antibody Breakdown Data by Type
4.1 Global CD137 Antibody Historic Market Size by Type (2018-2024)
4.2 Global CD137 Antibody Forecasted Market Size by Type (2024-2029)
5 CD137 Antibody Breakdown Data by Application
5.1 Global CD137 Antibody Historic Market Size by Application (2018-2024)
5.2 Global CD137 Antibody Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America CD137 Antibody Market Size (2018-2029)
6.2 North America CD137 Antibody Market Size by Type
6.2.1 North America CD137 Antibody Market Size by Type (2018-2024)
6.2.2 North America CD137 Antibody Market Size by Type (2024-2029)
6.2.3 North America CD137 Antibody Market Share by Type (2018-2029)
6.3 North America CD137 Antibody Market Size by Application
6.3.1 North America CD137 Antibody Market Size by Application (2018-2024)
6.3.2 North America CD137 Antibody Market Size by Application (2024-2029)
6.3.3 North America CD137 Antibody Market Share by Application (2018-2029)
6.4 North America CD137 Antibody Market Size by Country
6.4.1 North America CD137 Antibody Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America CD137 Antibody Market Size by Country (2018-2024)
6.4.3 North America CD137 Antibody Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe CD137 Antibody Market Size (2018-2029)
7.2 Europe CD137 Antibody Market Size by Type
7.2.1 Europe CD137 Antibody Market Size by Type (2018-2024)
7.2.2 Europe CD137 Antibody Market Size by Type (2024-2029)
7.2.3 Europe CD137 Antibody Market Share by Type (2018-2029)
7.3 Europe CD137 Antibody Market Size by Application
7.3.1 Europe CD137 Antibody Market Size by Application (2018-2024)
7.3.2 Europe CD137 Antibody Market Size by Application (2024-2029)
7.3.3 Europe CD137 Antibody Market Share by Application (2018-2029)
7.4 Europe CD137 Antibody Market Size by Country
7.4.1 Europe CD137 Antibody Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe CD137 Antibody Market Size by Country (2018-2024)
7.4.3 Europe CD137 Antibody Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China CD137 Antibody Market Size (2018-2029)
8.2 China CD137 Antibody Market Size by Type
8.2.1 China CD137 Antibody Market Size by Type (2018-2024)
8.2.2 China CD137 Antibody Market Size by Type (2024-2029)
8.2.3 China CD137 Antibody Market Share by Type (2018-2029)
8.3 China CD137 Antibody Market Size by Application
8.3.1 China CD137 Antibody Market Size by Application (2018-2024)
8.3.2 China CD137 Antibody Market Size by Application (2024-2029)
8.3.3 China CD137 Antibody Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia CD137 Antibody Market Size (2018-2029)
9.2 Asia CD137 Antibody Market Size by Type
9.2.1 Asia CD137 Antibody Market Size by Type (2018-2024)
9.2.2 Asia CD137 Antibody Market Size by Type (2024-2029)
9.2.3 Asia CD137 Antibody Market Share by Type (2018-2029)
9.3 Asia CD137 Antibody Market Size by Application
9.3.1 Asia CD137 Antibody Market Size by Application (2018-2024)
9.3.2 Asia CD137 Antibody Market Size by Application (2024-2029)
9.3.3 Asia CD137 Antibody Market Share by Application (2018-2029)
9.4 Asia CD137 Antibody Market Size by Region
9.4.1 Asia CD137 Antibody Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia CD137 Antibody Market Size by Region (2018-2024)
9.4.3 Asia CD137 Antibody Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America CD137 Antibody Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America CD137 Antibody Market Size by Type
10.2.1 Middle East, Africa, and Latin America CD137 Antibody Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America CD137 Antibody Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America CD137 Antibody Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America CD137 Antibody Market Size by Application
10.3.1 Middle East, Africa, and Latin America CD137 Antibody Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America CD137 Antibody Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America CD137 Antibody Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America CD137 Antibody Market Size by Country
10.4.1 Middle East, Africa, and Latin America CD137 Antibody Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America CD137 Antibody Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America CD137 Antibody Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sino Biological, Inc.
11.1.1 Sino Biological, Inc. Company Details
11.1.2 Sino Biological, Inc. Business Overview
11.1.3 Sino Biological, Inc. CD137 Antibody Introduction
11.1.4 Sino Biological, Inc. Revenue in CD137 Antibody Business (2018-2024)
11.1.5 Sino Biological, Inc. Recent Developments
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Details
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher CD137 Antibody Introduction
11.2.4 Thermo Fisher Revenue in CD137 Antibody Business (2018-2024)
11.2.5 Thermo Fisher Recent Developments
11.3 LifeSpan BioSciences, Inc
11.3.1 LifeSpan BioSciences, Inc Company Details
11.3.2 LifeSpan BioSciences, Inc Business Overview
11.3.3 LifeSpan BioSciences, Inc CD137 Antibody Introduction
11.3.4 LifeSpan BioSciences, Inc Revenue in CD137 Antibody Business (2018-2024)
11.3.5 LifeSpan BioSciences, Inc Recent Developments
11.4 BioLegend
11.4.1 BioLegend Company Details
11.4.2 BioLegend Business Overview
11.4.3 BioLegend CD137 Antibody Introduction
11.4.4 BioLegend Revenue in CD137 Antibody Business (2018-2024)
11.4.5 BioLegend Recent Developments
11.5 Abcam
11.5.1 Abcam Company Details
11.5.2 Abcam Business Overview
11.5.3 Abcam CD137 Antibody Introduction
11.5.4 Abcam Revenue in CD137 Antibody Business (2018-2024)
11.5.5 Abcam Recent Developments
11.6 Bio-Techne
11.6.1 Bio-Techne Company Details
11.6.2 Bio-Techne Business Overview
11.6.3 Bio-Techne CD137 Antibody Introduction
11.6.4 Bio-Techne Revenue in CD137 Antibody Business (2018-2024)
11.6.5 Bio-Techne Recent Developments
11.7 GeneTex
11.7.1 GeneTex Company Details
11.7.2 GeneTex Business Overview
11.7.3 GeneTex CD137 Antibody Introduction
11.7.4 GeneTex Revenue in CD137 Antibody Business (2018-2024)
11.7.5 GeneTex Recent Developments
11.8 Bio-Rad Laboratories, Inc.
11.8.1 Bio-Rad Laboratories, Inc. Company Details
11.8.2 Bio-Rad Laboratories, Inc. Business Overview
11.8.3 Bio-Rad Laboratories, Inc. CD137 Antibody Introduction
11.8.4 Bio-Rad Laboratories, Inc. Revenue in CD137 Antibody Business (2018-2024)
11.8.5 Bio-Rad Laboratories, Inc. Recent Developments
11.9 Arigo Biolaboratories Corp.
11.9.1 Arigo Biolaboratories Corp. Company Details
11.9.2 Arigo Biolaboratories Corp. Business Overview
11.9.3 Arigo Biolaboratories Corp. CD137 Antibody Introduction
11.9.4 Arigo Biolaboratories Corp. Revenue in CD137 Antibody Business (2018-2024)
11.9.5 Arigo Biolaboratories Corp. Recent Developments
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck CD137 Antibody Introduction
11.10.4 Merck Revenue in CD137 Antibody Business (2018-2024)
11.10.5 Merck Recent Developments
11.11 Cell Signaling Technology, Inc.
11.11.1 Cell Signaling Technology, Inc. Company Details
11.11.2 Cell Signaling Technology, Inc. Business Overview
11.11.3 Cell Signaling Technology, Inc. CD137 Antibody Introduction
11.11.4 Cell Signaling Technology, Inc. Revenue in CD137 Antibody Business (2018-2024)
11.11.5 Cell Signaling Technology, Inc. Recent Developments
11.12 MyBiosource, Inc.
11.12.1 MyBiosource, Inc. Company Details
11.12.2 MyBiosource, Inc. Business Overview
11.12.3 MyBiosource, Inc. CD137 Antibody Introduction
11.12.4 MyBiosource, Inc. Revenue in CD137 Antibody Business (2018-2024)
11.12.5 MyBiosource, Inc. Recent Developments
11.13 Boster Biological Technology
11.13.1 Boster Biological Technology Company Details
11.13.2 Boster Biological Technology Business Overview
11.13.3 Boster Biological Technology CD137 Antibody Introduction
11.13.4 Boster Biological Technology Revenue in CD137 Antibody Business (2018-2024)
11.13.5 Boster Biological Technology Recent Developments
11.14 Biocare Medical, LLC
11.14.1 Biocare Medical, LLC Company Details
11.14.2 Biocare Medical, LLC Business Overview
11.14.3 Biocare Medical, LLC CD137 Antibody Introduction
11.14.4 Biocare Medical, LLC Revenue in CD137 Antibody Business (2018-2024)
11.14.5 Biocare Medical, LLC Recent Developments
11.15 Signalway Antibody LLC
11.15.1 Signalway Antibody LLC Company Details
11.15.2 Signalway Antibody LLC Business Overview
11.15.3 Signalway Antibody LLC CD137 Antibody Introduction
11.15.4 Signalway Antibody LLC Revenue in CD137 Antibody Business (2018-2024)
11.15.5 Signalway Antibody LLC Recent Developments
11.16 NSJ Bioreagents
11.16.1 NSJ Bioreagents Company Details
11.16.2 NSJ Bioreagents Business Overview
11.16.3 NSJ Bioreagents CD137 Antibody Introduction
11.16.4 NSJ Bioreagents Revenue in CD137 Antibody Business (2018-2024)
11.16.5 NSJ Bioreagents Recent Developments
11.17 Leinco Technologies
11.17.1 Leinco Technologies Company Details
11.17.2 Leinco Technologies Business Overview
11.17.3 Leinco Technologies CD137 Antibody Introduction
11.17.4 Leinco Technologies Revenue in CD137 Antibody Business (2018-2024)
11.17.5 Leinco Technologies Recent Developments
11.18 Wuhan Fine Biotech Co., Ltd.
11.18.1 Wuhan Fine Biotech Co., Ltd. Company Details
11.18.2 Wuhan Fine Biotech Co., Ltd. Business Overview
11.18.3 Wuhan Fine Biotech Co., Ltd. CD137 Antibody Introduction
11.18.4 Wuhan Fine Biotech Co., Ltd. Revenue in CD137 Antibody Business (2018-2024)
11.18.5 Wuhan Fine Biotech Co., Ltd. Recent Developments
11.19 Elabscience Biotechnology Inc.
11.19.1 Elabscience Biotechnology Inc. Company Details
11.19.2 Elabscience Biotechnology Inc. Business Overview
11.19.3 Elabscience Biotechnology Inc. CD137 Antibody Introduction
11.19.4 Elabscience Biotechnology Inc. Revenue in CD137 Antibody Business (2018-2024)
11.19.5 Elabscience Biotechnology Inc. Recent Developments
11.20 Biotium
11.20.1 Biotium Company Details
11.20.2 Biotium Business Overview
11.20.3 Biotium CD137 Antibody Introduction
11.20.4 Biotium Revenue in CD137 Antibody Business (2018-2024)
11.20.5 Biotium Recent Developments
11.21 Bioss Inc
11.21.1 Bioss Inc Company Details
11.21.2 Bioss Inc Business Overview
11.21.3 Bioss Inc CD137 Antibody Introduction
11.21.4 Bioss Inc Revenue in CD137 Antibody Business (2018-2024)
11.21.5 Bioss Inc Recent Developments
11.22 Miltenyi Biotec
11.22.1 Miltenyi Biotec Company Details
11.22.2 Miltenyi Biotec Business Overview
11.22.3 Miltenyi Biotec CD137 Antibody Introduction
11.22.4 Miltenyi Biotec Revenue in CD137 Antibody Business (2018-2024)
11.22.5 Miltenyi Biotec Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CD137 Antibody Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Monoclonal Antibody
Table 3. Key Players of Polyclonal Antibody
Table 4. Global CD137 Antibody Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global CD137 Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global CD137 Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global CD137 Antibody Market Share by Region (2018-2024)
Table 8. Global CD137 Antibody Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global CD137 Antibody Market Share by Region (2024-2029)
Table 10. CD137 Antibody Market Trends
Table 11. CD137 Antibody Market Drivers
Table 12. CD137 Antibody Market Challenges
Table 13. CD137 Antibody Market Restraints
Table 14. Global CD137 Antibody Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global CD137 Antibody Revenue Share by Players (2018-2024)
Table 16. Global Top CD137 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD137 Antibody as of 2022)
Table 17. Global CD137 Antibody Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by CD137 Antibody Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of CD137 Antibody, Headquarters and Area Served
Table 20. Global Key Players of CD137 Antibody, Product and Application
Table 21. Global Key Players of CD137 Antibody, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CD137 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global CD137 Antibody Revenue Market Share by Type (2018-2024)
Table 25. Global CD137 Antibody Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global CD137 Antibody Revenue Market Share by Type (2024-2029)
Table 27. Global CD137 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global CD137 Antibody Revenue Share by Application (2018-2024)
Table 29. Global CD137 Antibody Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global CD137 Antibody Revenue Share by Application (2024-2029)
Table 31. North America CD137 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America CD137 Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America CD137 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America CD137 Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America CD137 Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America CD137 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America CD137 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe CD137 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe CD137 Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe CD137 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe CD137 Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe CD137 Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe CD137 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe CD137 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 45. China CD137 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 46. China CD137 Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 47. China CD137 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 48. China CD137 Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia CD137 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia CD137 Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia CD137 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia CD137 Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia CD137 Antibody Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia CD137 Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia CD137 Antibody Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America CD137 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America CD137 Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America CD137 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America CD137 Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America CD137 Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America CD137 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America CD137 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 63. Sino Biological, Inc. Company Details
Table 64. Sino Biological, Inc. Business Overview
Table 65. Sino Biological, Inc. CD137 Antibody Product
Table 66. Sino Biological, Inc. Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 67. Sino Biological, Inc. Recent Developments
Table 68. Thermo Fisher Company Details
Table 69. Thermo Fisher Business Overview
Table 70. Thermo Fisher CD137 Antibody Product
Table 71. Thermo Fisher Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 72. Thermo Fisher Recent Developments
Table 73. LifeSpan BioSciences, Inc Company Details
Table 74. LifeSpan BioSciences, Inc Business Overview
Table 75. LifeSpan BioSciences, Inc CD137 Antibody Product
Table 76. LifeSpan BioSciences, Inc Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 77. LifeSpan BioSciences, Inc Recent Developments
Table 78. BioLegend Company Details
Table 79. BioLegend Business Overview
Table 80. BioLegend CD137 Antibody Product
Table 81. BioLegend Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 82. BioLegend Recent Developments
Table 83. Abcam Company Details
Table 84. Abcam Business Overview
Table 85. Abcam CD137 Antibody Product
Table 86. Abcam Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 87. Abcam Recent Developments
Table 88. Bio-Techne Company Details
Table 89. Bio-Techne Business Overview
Table 90. Bio-Techne CD137 Antibody Product
Table 91. Bio-Techne Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 92. Bio-Techne Recent Developments
Table 93. GeneTex Company Details
Table 94. GeneTex Business Overview
Table 95. GeneTex CD137 Antibody Product
Table 96. GeneTex Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 97. GeneTex Recent Developments
Table 98. Bio-Rad Laboratories, Inc. Company Details
Table 99. Bio-Rad Laboratories, Inc. Business Overview
Table 100. Bio-Rad Laboratories, Inc. CD137 Antibody Product
Table 101. Bio-Rad Laboratories, Inc. Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 102. Bio-Rad Laboratories, Inc. Recent Developments
Table 103. Arigo Biolaboratories Corp. Company Details
Table 104. Arigo Biolaboratories Corp. Business Overview
Table 105. Arigo Biolaboratories Corp. CD137 Antibody Product
Table 106. Arigo Biolaboratories Corp. Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 107. Arigo Biolaboratories Corp. Recent Developments
Table 108. Merck Company Details
Table 109. Merck Business Overview
Table 110. Merck CD137 Antibody Product
Table 111. Merck Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 112. Merck Recent Developments
Table 113. Cell Signaling Technology, Inc. Company Details
Table 114. Cell Signaling Technology, Inc. Business Overview
Table 115. Cell Signaling Technology, Inc. CD137 Antibody Product
Table 116. Cell Signaling Technology, Inc. Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 117. Cell Signaling Technology, Inc. Recent Developments
Table 118. MyBiosource, Inc. Company Details
Table 119. MyBiosource, Inc. Business Overview
Table 120. MyBiosource, Inc. CD137 Antibody Product
Table 121. MyBiosource, Inc. Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 122. MyBiosource, Inc. Recent Developments
Table 123. Boster Biological Technology Company Details
Table 124. Boster Biological Technology Business Overview
Table 125. Boster Biological Technology CD137 Antibody Product
Table 126. Boster Biological Technology Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 127. Boster Biological Technology Recent Developments
Table 128. Biocare Medical, LLC Company Details
Table 129. Biocare Medical, LLC Business Overview
Table 130. Biocare Medical, LLC CD137 Antibody Product
Table 131. Biocare Medical, LLC Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 132. Biocare Medical, LLC Recent Developments
Table 133. Signalway Antibody LLC Company Details
Table 134. Signalway Antibody LLC Business Overview
Table 135. Signalway Antibody LLC CD137 Antibody Product
Table 136. Signalway Antibody LLC Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 137. Signalway Antibody LLC Recent Developments
Table 138. NSJ Bioreagents Company Details
Table 139. NSJ Bioreagents Business Overview
Table 140. NSJ Bioreagents CD137 Antibody Product
Table 141. NSJ Bioreagents Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 142. NSJ Bioreagents Recent Developments
Table 143. Leinco Technologies Company Details
Table 144. Leinco Technologies Business Overview
Table 145. Leinco Technologies CD137 Antibody Product
Table 146. Leinco Technologies Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 147. Leinco Technologies Recent Developments
Table 148. Wuhan Fine Biotech Co., Ltd. Company Details
Table 149. Wuhan Fine Biotech Co., Ltd. Business Overview
Table 150. Wuhan Fine Biotech Co., Ltd. CD137 Antibody Product
Table 151. Wuhan Fine Biotech Co., Ltd. Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 152. Wuhan Fine Biotech Co., Ltd. Recent Developments
Table 153. Elabscience Biotechnology Inc. Company Details
Table 154. Elabscience Biotechnology Inc. Business Overview
Table 155. Elabscience Biotechnology Inc. CD137 Antibody Product
Table 156. Elabscience Biotechnology Inc. Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 157. Elabscience Biotechnology Inc. Recent Developments
Table 158. Biotium Company Details
Table 159. Biotium Business Overview
Table 160. Biotium CD137 Antibody Product
Table 161. Biotium Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 162. Biotium Recent Developments
Table 163. Bioss Inc Company Details
Table 164. Bioss Inc Business Overview
Table 165. Bioss Inc CD137 Antibody Product
Table 166. Bioss Inc Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 167. Bioss Inc Recent Developments
Table 168. Miltenyi Biotec Company Details
Table 169. Miltenyi Biotec Business Overview
Table 170. Miltenyi Biotec CD137 Antibody Product
Table 171. Miltenyi Biotec Revenue in CD137 Antibody Business (2018-2024) & (US$ Million)
Table 172. Miltenyi Biotec Recent Developments
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CD137 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global CD137 Antibody Market Share by Type: 2022 VS 2029
Figure 3. Monoclonal Antibody Features
Figure 4. Polyclonal Antibody Features
Figure 5. Global CD137 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global CD137 Antibody Market Share by Application: 2022 VS 2029
Figure 7. Flow Cytometry Case Studies
Figure 8. ELISA Case Studies
Figure 9. Immunoprecipitation Case Studies
Figure 10. Others Case Studies
Figure 11. CD137 Antibody Report Years Considered
Figure 12. Global CD137 Antibody Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global CD137 Antibody Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global CD137 Antibody Market Share by Region: 2022 VS 2029
Figure 15. Global CD137 Antibody Market Share by Players in 2022
Figure 16. Global Top CD137 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD137 Antibody as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by CD137 Antibody Revenue in 2022
Figure 18. North America CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America CD137 Antibody Market Share by Type (2018-2029)
Figure 20. North America CD137 Antibody Market Share by Application (2018-2029)
Figure 21. North America CD137 Antibody Market Share by Country (2018-2029)
Figure 22. United States CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe CD137 Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe CD137 Antibody Market Share by Type (2018-2029)
Figure 26. Europe CD137 Antibody Market Share by Application (2018-2029)
Figure 27. Europe CD137 Antibody Market Share by Country (2018-2029)
Figure 28. Germany CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China CD137 Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China CD137 Antibody Market Share by Type (2018-2029)
Figure 36. China CD137 Antibody Market Share by Application (2018-2029)
Figure 37. Asia CD137 Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia CD137 Antibody Market Share by Type (2018-2029)
Figure 39. Asia CD137 Antibody Market Share by Application (2018-2029)
Figure 40. Asia CD137 Antibody Market Share by Region (2018-2029)
Figure 41. Japan CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America CD137 Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America CD137 Antibody Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America CD137 Antibody Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America CD137 Antibody Market Share by Country (2018-2029)
Figure 51. Brazil CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries CD137 Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Sino Biological, Inc. Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 58. Thermo Fisher Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 59. LifeSpan BioSciences, Inc Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 60. BioLegend Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 61. Abcam Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 62. Bio-Techne Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 63. GeneTex Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 64. Bio-Rad Laboratories, Inc. Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 65. Arigo Biolaboratories Corp. Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 66. Merck Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 67. Cell Signaling Technology, Inc. Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 68. MyBiosource, Inc. Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 69. Boster Biological Technology Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 70. Biocare Medical, LLC Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 71. Signalway Antibody LLC Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 72. NSJ Bioreagents Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 73. Leinco Technologies Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 74. Wuhan Fine Biotech Co., Ltd. Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 75. Elabscience Biotechnology Inc. Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 76. Biotium Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 77. Bioss Inc Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 78. Miltenyi Biotec Revenue Growth Rate in CD137 Antibody Business (2018-2024)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed